Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
8
×
national blog main
life sciences
national top stories
san francisco blog main
startups
biotech
boston blog main
new york blog main
san diego blog main
san diego top stories
boston top stories
cancer
new york top stories
san francisco top stories
seattle blog main
seattle top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
texas blog main
texas top stories
vc
wisconsin blog main
wisconsin top stories
clinical trials
eli lilly
generic drugs
ipo
takeda pharmaceutical
venture capital
armo biosciences
avalon ventures
What
drugs
8
×
bio
roundup
new
advance
aims
biology
cytokine
drug
enhanced
fda
patients
pharmaceutical
san
suite
synthetic
synthorx
ahead
appetite
approach
aren’t
asco
bails
based
biologic
biotech
black
brand
branded
bread
bridgebio
butter
buyout
called
cancer
capital
car
cash
changes
choices
Language
unset
Current search:
deals
×
drugs
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Xealth Gets $11M, Aims to Be Surescripts of Digital Health Services
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs